Related Experiment Video
Updated: Aug 9, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
Lipoprotein (a) in patients with spontaneous venous thromboembolism
Rainer Vormittag1, Thomas Vukovich, Milena Stain
1Department of Internal Medicine I, Division of Hematology and Blood Coagulation, University Hospital of Vienna, Austria.
Insights
Elevated lipoprotein (a) (Lp (a)) is not associated with an increased risk of venous thromboembolism (VTE). This study found no significant difference in Lp (a) levels between patients with deep vein thrombosis or pulmonary embolism and healthy controls.
Area of Science:
- Cardiovascular Medicine
- Thrombosis Research
- Lipidology
Background:
- Elevated lipoprotein (a) (Lp (a)) is a known risk factor for coronary heart disease and stroke.
- Previous studies on the association between Lp (a) and venous thromboembolism (VTE) have yielded contradictory results.
- Investigating Lp (a) as a potential independent risk factor for VTE is crucial for understanding thrombosis risk profiles.
Purpose of the Study:
- To determine if elevated Lp (a) levels are an independent risk factor for spontaneous symptomatic VTE.
- To compare risk profiles between patients with thrombosis and healthy controls.
- To analyze differences in Lp (a) levels in patients with deep vein thrombosis (DVT) and pulmonary embolism (PE).
Main Methods:
- Investigated Lp (a) levels in 128 patients with DVT, 105 patients with PE, and 122 healthy controls.
- Measured Lp (a) using an immunoturbidimetric assay (Tina-quant(R), Roche).
- Analyzed Lp (a) levels as both continuous and categorical variables (above 300 mg/L).
Main Results:
- Median Lp (a) levels (mg/L) were similar across groups: 170 in DVT patients, 140 in PE patients, and 126 in controls.
- Odds ratios for VTE per 100 mg/L increase in Lp (a) were not statistically significant.
- Prevalence of Lp (a) > 300 mg/L did not differ significantly among DVT, PE, and control groups.
Conclusions:
- No association was found between Lp (a) levels and the risk of VTE.
- This finding applies regardless of whether DVT occurred with or without PE.
- Lp (a) does not appear to be an independent risk factor for spontaneous symptomatic VTE.
Introduction:
Elevated lipoprotein (a) (Lp (a)) has been established as a risk factor of coronary heart disease and stroke. Findings concerning the risk of venous thromboembolism (VTE) in adults are contradictory. The aim of our study was to investigate, whether elevated Lp (a) levels are an independent risk factor of spontaneous symptomatic venous thromboembolism (VTE). Our study was further designed to detect differences in risk profiles between thrombosis patients with and without symptomatic PE.
Materials And Methods:
We investigated Lp (a) in 128 patients with spontaneous symptomatic deep vein thrombosis (DVT, group 1), 105 with spontaneous symptomatic pulmonary embolism with or without DVT (PE, group 2) and 122 healthy controls. Lp (a) was measured with an immunoturbidimetric assay (Tina-quant(R), Roche, Grenzach-Wyhlen, Germany) on a Hitachi-Modular system.
Results:
Lp (a) levels (mg/L) were not significantly different among groups, median levels (25th-75th percentiles) were 170 (51-386) in group 1, 140 (<20-427) in group 2 and 126 (54-331) in controls, respectively. As continuous variable, odds ratios for VTE for a 100 mg/L increase of Lp (a) were 1.1 [95% confidence interval 0.98-1.2] for group 1 versus controls and 1.1 [0.95-1.2] for group 2 versus controls. The prevalence of Lp (a) above 300 mg/L was not significantly different among patients and controls (group 1: 30%, group 2: 32% and controls: 25%, p=0.4, p=0.2, respectively).
Conclusions:
In conclusion we found no association between Lp (a) and VTE regardless whether DVT occurred together with PE or not.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...